Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT04040231
- Phase
- PHASE1
- Status
- Completed
Conditions
- Mesothelioma
- Pleural Mesothelioma
- Wilms Tumor
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Galinpepimut-S — BIOLOGICALGalinpepimut-S will be administered alone on weeks 0 and 2. Participants will receive the galinpepimut-S vaccine and nivolumab over 16 weeks in the initial treatment phase.
- Nivolumab — DRUGParticipants will receive nivolumab and the galinpepimut-S vaccine over 16 weeks in the initial treatment phase.
- Sargramostim — BIOLOGICALAll participants will receive Sargramostim (GM-CSF) 70 mcg injected subcutaneously on days 0 and -2 of each cycle
Study Details
The purpose of this study is to test whether it is safe to give Galinpepimut-S and Nivolumab together in patients with mesothelioma.
Key Dates
- Start date
- Jul 24, 2019
- Status verified
- Nov 2024
- Primary completion
- Nov 14, 2024
- Completion
- Nov 14, 2024
Study Design
- Enrollment
- 10 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Malignant Pleural Mesothelioma (MPM)Participants with previously treated Malignant Pleural Mesothelioma/MPM
Primary Outcome Measure
Maximum tolerated dose [ Time Frame: up to 24 months ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Cancer Center @ Commack | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | - |
| Memorial Sloan - Kettering Cancer Center | New York | New York | 10021 | - |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | - |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge· Basking Ridge, NJMemorial Sloan Kettering Monmouth· Middletown, NJMemorial Sloan Kettering Cancer Center @ Commack· Commack, NYMemorial Sloan Kettering Westchester· Harrison, NYMemorial Sloan - Kettering Cancer Center· New York, NYMemorial Sloan Kettering Nassau· Uniondale, NY
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California
- Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesPHASE1 · Recruiting · New York Medical College · Valhalla, New York
- Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsPHASE1/PHASE2 · Recruiting · Vivace Therapeutics, Inc · San Francisco, California